Emily Tomlinson, MD

Clinical fellow
Pediatric Hematology-Oncology

I am a clinical pediatric hematology/oncology fellow at UCSF. My research interests include improving outcomes in pediatric leukemia through mitigation of treatment toxicity and further understanding its pathogenesis, especially in underserved populations. My project in the Avagyan lab explores the role of environmental risk factors associated with adverse social determinants of health in the prenatal origin of leukemia-predisposing clones in utero through inflammatory pathway upregulation. Unlike many poor prognostic predictors of pediatric B-cell acute lymphoblastic leukemia, environmental risk factors are modifiable. Understanding inflammatory pathways involved with environmental stressors would allow for targeting protective biologic mechanisms, to one day alter the course of pre-leukemia by early identification and prevention of progression.

Publications: 

Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel.

Blood advances

Naik S, Selukar S, Talleur AC, Deshpande S, Llaurador Caraballo G, Fabrizio VA, Rouce RH, Zeng XL, Vatsayan A, Rossoff J, Pacenta HL, John S, Phillips CL, Talano JM, Moskop A, Verneris MR, Myers GD, Hall EM, Karras NA, Bonifant CL, Qayed M, Bakinowski E, Keating A, Baumeister SHC, Tomilson E, Hermiston ML, Satwani P, Krupski C, Chinnabhandar V, Stefanski HE, Egeler E, Curran KJ, Laetsch TW, Mackall CL, Prabhu S, Nguyen K, Baggott C, Schultz LM, McNerney KO

TotShots: An Innovative Pediatric Free Clinic Providing High Patient Satisfaction to the Underserved.

Family medicine

LaGrandeur J, Moros M, Dobrick J, Rahimian R, Siyahian A, Tomlinson E, Gordon P